Skip to main content

Table 1 Clinical characteristics, blood tests and cardiovascular assessment of patients with type 2 diabetes mellitus (T2DM) and controls

From: Association of subclinical myocardial injury with arterial stiffness in patients with type 2 diabetes mellitus

Parameters T2DM Controls P value
  (n = 100) (n = 150)  
Age, years 62±10 60±9 0.20
Female, % (n) 53 (53) 51(77) 0.90
Systolic blood pressure, mmHg 138±19 121±19 <0.01
Diastolic blood pressure, mmHg 77±9 74±9 0.01
Body mass index, kg/m2 25.5±4.2 23.5±3.4 <0.01
Medical history
Current smoker, % (n) 26 (26) 18 (27) 0.16
Hypertension, % (n) 61 (61) 11 (17) <0.01
Hypercholesterolemia, % (n) 60 (60) 27 (40) <0.01
Serum lipid profile, renal function and inflammatory marker
Total cholesterol, mmol/L 4.9±0.9 5.1±0.8 0.15
Triglycerides, mmol/L 1.5±0.8 1.3±0.7 0.03
High density lipoprotein, mmol/L 1.4±0.4 1.5±0.4 <0.01
Low density lipoprotein, mmol/L 2.8±0.7 3.0±0.7 0.10
Creatinine, μmol/l 80±23 75±15 0.03
Fasting glucose, mmol/L 7.4±2.1 5.0±0.5 <0.01
HbA1c, % 7.6±1.2 5.9±0.4 <0.01
hs-CRP, mg/L 2.3±5.3 2.3±5.2 0.98
hs-TnI, μg/L 5.7±9.2 3.2±1.9 <0.01
Elevated hs-TnI, %(n) 10 (10) 1 (1) <0.01
Cardiovascular assessment    
ba-PWV, ms-1 17.98±3.91 15.70±2.96 <0.01
Brachial FMD, % 2.6±3.5 5.5±4.2 <0.01
Carotid IMT, mm 0.96±0.20 0.86±0.14 <0.01
  1. Abbreviations: ba-PWV brachial ankle pulse wave velocity, FMD flow mediated dilatation, hs-CRP high sensitivity C-reactive protein, hs-TnI high sensitivity Troponin I, IMT intima media thickness.